Glens Falls Hospital is the first site in the United States to be activated for a COVID-19 Study: A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-group, Multi-center Study of an Inhaled Pan-Janus Kinase Inhibitor, TD-0903, to Treat Symptomatic Acute Lung Injury Associated with COVID-19.
The Sponsor of this study, Theravance Biopharma Ireland Limited, is developing a new investigational drug to treat acute lung injury (ALI) associated with COVID-19. The aim of this study is to determine whether the drug may help treat lung injury and breathing difficulties in participants admitted to the hospital with COVID-19. The ongoing study will recruit approximately 200 participants overall at sites in multiple countries including the United States. The Glens Falls Hospital site will be responsible for several participants in the trial – the first patient was enrolled in the program this week.
Dr. Bill Papura, Associate Chief Medical Officer, is GFH’s Principal Investigator of the study, which is a collaborative effort between the pharmacy, laboratory and respiratory therapy departments.
About Glens Falls Hospital
Glens Falls Hospital (GFH) maintains a service area that spans 6,000 square miles across 5 diverse counties. Founded in 1897, GFH today operates an advanced health care delivery system featuring more than 20 regional facilities. A vast array of specialized medical and surgical services are provided in addition to coronary care, behavioral health care, rehabilitation and wellness and others. The main hospital campus is home to the C.R. Wood Cancer Center, the Joyce Stock Snuggery birthing center, the Breast Center and a chronic wound healing center. GFH is a not-for-profit organization and the largest employer in New York’s Adirondack region, with over 2,500 employees and a medical staff of over 460 providers. For more information visit www.GlensFallsHospital.org.
About the Albany Med Health System
Glens Falls Hospital is an affiliate of the Albany Med Health System, which also includes Albany Medical Center, Columbia Memorial Health and Saratoga Hospital. The region’s largest locally governed health system, it has 1,520 beds, more than 800 physicians and 125 outpatient locations throughout the Capital Region.
About Theravance Biopharma Ireland, Ltd.
Theravance Biopharma, Inc. (“Theravance Biopharma”) is a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines.
For more information please contact:
Glens Falls Hospital – Ray Agnew, (518) 926-5900